Rocket


News + Filings
Transactions
Holdings

Matrix Capital Management Company, LP > ADAP

DateNameTickerSharesChangeValueChangePrice
06/30/2023Adaptimmune Therapeutics PLCADAP38,974,185036,051,121,00036,009,224,000$925.00
09/30/2022Adaptimmune Therapeutics PLCADAP38,974,185041,897,000-24,359,000$1.07
06/30/2022Adaptimmune Therapeutics PLCADAP38,974,185066,256,000-14,031,000$1.70
03/31/2022Adaptimmune Therapeutics PLCADAP38,974,185080,287,000-65,866,000$2.06
12/31/2021Adaptimmune Therapeutics PLCADAP38,974,1850146,153,000-19,877,000$3.75
06/30/2021Adaptimmune Therapeutics PLCADAP38,974,1850166,030,000-44,041,000$4.26
12/31/2020Adaptimmune Therapeutics PLCADAP38,974,1850210,071,000-100,943,000$5.39
09/30/2020Adaptimmune Therapeutics PLCADAP38,974,1850311,014,000-79,118,000$7.98
06/30/2020Adaptimmune Therapeutics PLCADAP38,974,1854,545,455390,132,000296,486,000$10.01
03/31/2020Adaptimmune Therapeutics PLCADAP34,428,7306,428,73093,646,00060,046,000$2.72
12/31/2019Adaptimmune Therapeutics PLCADAP28,000,000033,600,000-8,680,000$1.20
09/30/2019Adaptimmune Therapeutics PLCADAP28,000,000042,280,000-70,280,000$1.51
06/30/2019Adaptimmune Therapeutics PLCADAP28,000,0000112,560,000-7,840,000$4.02
03/31/2019Adaptimmune Therapeutics PLCADAP28,000,000851,000120,400,000-35,707,000$4.30
12/31/2018Adaptimmune Therapeutics PLCADAP27,149,0006,786,989156,107,000-120,002,000$5.75
09/30/2018Adaptimmune Therapeutics PLCADAP20,362,0116,278,500276,109,000108,938,000$13.56
06/30/2018Adaptimmune Therapeutics PLCADAP14,083,511201,500167,171,00011,276,000$11.87
03/31/2018Adaptimmune Therapeutics PLCADAP13,882,0111,668,500155,895,00074,309,000$11.23
12/31/2017Adaptimmune Therapeutics PLCADAP12,213,511170,00081,586,000-17,050,000$6.68
09/30/2017Adaptimmune Therapeutics PLCADAP12,043,5113,351,42898,636,00059,609,000$8.19
08/31/2017Adaptimmune Therapeutics PLCADAP72,261,06663,568,983505,827,462466,800,462$7.00
06/30/2017Adaptimmune Therapeutics PLCADAP8,692,0838,692,08339,027,00039,027,000$4.49
<< Prev     Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy